Fierce Biotech
Debut Biotech makes its entrance with a $22M series A for cell-free biomanufacturing facility
Two-year-old biomanufacturing upstart Debut Biotech, led by CEO Joshua Britton, has already inked partnerships with Battelle, DSM and DIC.
PRWeb
Debut Biotech Raises $22.6M Series A to Commercialize High-Value Ingredients from Proprietary Cell-Free Biomanufacturing Platform
Novel ingredients bring unique advantages to cosmetic, food, and health and wellness markets in one of the largest Series A financing rounds in synthetic biology space
Cosmetics Design
Debut Biotechnology partners with DIC on cosmetic pigment production
Biotech promises to be the future of chemical synthesis and is already used to manufacture numerous cosmetics and personal care ingredients. The Debut-DIC deal is on track to deliver not only a new source for cosmetics pigments but also to showcase a new sort of biotech platform.
Business Insider
Meet the 24 biotech startups that top VCs say are poised to take off in the next 12 months
Every day seems to bring a fundraising record and a new company launching in the biotech industry. Insider spoke with some of the smartest and most plugged-in venture capitalists in biotech to pinpoint the most exciting startups.
